Medivir selects Certara's D360 as its global drug discovery platform

29-01-2014 pharmabiz.comComments (0)

MedivirPharmaceutical

Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected Certara's D360 as its global drug discovery platform. Certara's D360 is an integrated solution for the query, analysis and ...

Read more on pharmabiz.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top